Skip to main content
Premium Trial:

Request an Annual Quote

A. Menarini to Distribute Credo Diagnostics Coronavirus Assay Kit, Respiratory Infection Assays

NEW YORK – A. Menarini Diagnostics and Credo Diagnostics Biomedical announced on Thursday an exclusive distribution agreement for Credo's SARS-CoV-2 assay kit and other assays for diagnosing respiratory syncytial virus and Group Strep A.

The tests run on Credo's VitaPCR, a CE-marked point-of-care molecular platform. The firms said that results for the coronavirus test, which use a nasal or oropharyngeal sample, can be achieved in 20 minutes. The test also recently received the CE mark

According to Credo's website, the VitaPCR requires two minutes of hands-on time and does not require extra equipment such as refrigeration.

Financial and other terms of the deal were not disclosed.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.